Animal study · mice and hamsters

Retatrutide cut body weight by 31% in obese mice with MASH

Checked against the paper Animal studyPublished by PepVault

The takeaway

In two obese animal models, retatrutide lowered weight, insulin resistance and liver fat measures, with some lean mass lost along with fat in the mice.

Kind
Animal study
Studied in
Mice and hamsters
Published
2026
Journal
Obesity (Silver Spring)

What they tested

The team tested whether retatrutide improves weight, insulin resistance and liver fat in obese mouse and hamster models of MASH, a form of fatty liver disease.

How the study was done

A preclinical study in mice and hamsters made obese by diet, comparing retatrutide with vehicle, an inactive control solution. Hamsters were treated for 5 weeks.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In mice, retatrutide lowered body weight by 31% against vehicle, with losses in both fat and lean mass and lower food and water intake in the first days, while energy expenditure did not change significantly. The mice also had a lower HOMA-IR, an index of insulin resistance, a lower liver fat score, and less fatty acid, triglyceride and total cholesterol content. In hamsters, retatrutide shifted eating toward plain chow and away from the high fat/cholesterol diet and 10% fructose water, and led to significant weight loss; lean mass was not different after 5 weeks and bone mineral density did not change. Hamsters had lower HOMA-IR, plasma triglycerides and LDL cholesterol, and 50% less liver triglyceride, though the liver tissue score did not improve.

What it doesn’t show

These results come from mice and hamsters, not people. In hamsters, the liver tissue score did not improve even though liver triglycerides fell.

The paper

Briand et al. Retatrutide Shows Multiple Metabolic Benefits in Diet-Induced Obese MASH Mouse and Hamster Models. Obesity (Silver Spring). 2026.

The compound

More studies on Retatrutide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo